LLY
Eli Lilly and Company
- Diluted EPS, 2025
- $22.95
- YoY, 2025
- +96.0%
- 5-year CAGR
- +27.6%
- 10-year CAGR
- +26.1%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $22.95 | +96.0% |
| 2024 | $11.71 | +101.9% |
| 2023 | $5.80 | −15.9% |
| 2022 | $6.90 | +12.7% |
| 2021 | $6.12 | −9.9% |
| 2020 | $6.79 | −23.6% |
| 2019 | $8.89 | +184.0% |
| 2018 | $3.13 | — |
| 2017 | −$0.19 | — |
| 2016 | $2.58 | +14.2% |
| 2015 | $2.26 | +1.3% |
| 2014 | $2.23 | −48.4% |
| 2013 | $4.32 | +18.0% |
| 2012 | $3.66 | −6.2% |
| 2011 | $3.90 | −14.8% |
| 2010 | $4.58 | +16.2% |
| 2009 | $3.94 | — |
| 2008 | −$1.89 | — |